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ABSTRACT Clostridium difficile is the major etiologic agent of antibiotic-associated
intestinal disease. Pathogenesis of C. difficile is mainly attributed to the production
and secretion of toxins A and B. Unlike most clostridial toxins, toxins A and B have
no signal peptide, and they are therefore secreted by unusual mechanisms involving
the holin-like TcdE protein and/or autolysis. In this study, we characterized the cell
surface protein Cwp19, a newly identified peptidoglycan-degrading enzyme contain-
ing a novel catalytic domain. We purified a recombinant His6-tagged Cwp19 protein
and showed that it has lytic transglycosylase activity. Moreover, we observed that
Cwp19 is involved in cell autolysis and that a C. difficile cwp19 mutant exhibited de-
layed autolysis in stationary phase compared to the wild type when bacteria were
grown in brain heart infusion (BHI) medium. Wild-type cell autolysis is correlated to
strong alterations of cell wall thickness and integrity and to release of cytoplasmic
material. Furthermore, we demonstrated that toxins were released into the extracel-
lular medium as a result of Cwp19-induced autolysis when cells were grown in BHI
medium. In contrast, Cwp19 did not induce autolysis or toxin release when cells
were grown in tryptone-yeast extract (TY) medium. These data provide evidence for
the first time that TcdE and bacteriolysis are coexisting mechanisms for toxin re-
lease, with their relative contributions in vitro depending on growth conditions.
Thus, Cwp19 is an important surface protein involved in autolysis of vegetative cells
of C. difficile that mediates the release of the toxins from the cell cytosol in response
to specific environment conditions.
IMPORTANCE Clostridium difficile-associated disease is mainly known as a health
care-associated infection. It represents the most problematic hospital-acquired infec-
tion in North America and Europe and exerts significant economic pressure on
health care systems. Virulent strains of C. difficile generally produce two toxins that
have been identified as the major virulence factors. The mechanism for release of
these toxins from bacterial cells is not yet fully understood but is thought to be
partly mediated by bacteriolysis. Here we identify a novel peptidoglycan hydrolase
in C. difficile, Cwp19, exhibiting lytic transglycosylase activity. We show that Cwp19
contributes to C. difficile cell autolysis in the stationary phase and, consequently, to
toxin release, most probably as a response to environmental conditions such as nu-
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tritional signals. These data highlight that Cwp19 constitutes a promising target for
the development of new preventive and curative strategies.
KEYWORDS Clostridium difficile, autolysins, lytic transglycosylase, peptidoglycan,
surface proteins, toxins
Clostridium difficile, a Gram-positive spore-forming bacterium, is the major cause ofintestinal disease associated with antibiotic therapy (1). C. difficile infection (CDI) is
a serious risk within health care environments and is increasingly recognized as a
community-associated disease (2, 3). Outbreaks leading to increased morbidity and
mortality have been associated with highly virulent strains such as BI/NAP1/027 (4). CDI
can result in a spectrum of symptoms, ranging from mild diarrhea to life-threatening
pseudomembranous colitis and colon perforation (5). The major virulence factors
mediating these symptoms are toxins A and B (TcdA and TcdB), which alter the actin
cytoskeleton of intestinal epithelial cells through glucosylation of Rho family proteins,
leading to a severe inflammatory response and inducing the symptoms associated with
CDI (6).
TcdA and TcdB belong to the family of large clostridial glucosylating toxins (LCGTs)
(7). A feature of LCGTs is that they are secreted without an identifiable secretion signal.
The tcdA and tcdB genes lie within a 19.6-kb pathogenicity locus (PaLoc), which also
includes three additional genes designated tcdR, tcdC, and tcdE. TcdR is an alternative
sigma factor that initiates transcription from the tcdA, tcdB, and tcdR promoters (8).
TcdC is thought to be an anti-sigma factor for TcdR (9), but its function is still a subject
of debate (10). TcdE is a protein with structural features similar to those found in holins
of bacteriophages (11) that has been shown to be involved in toxin release from
C. difficile cells (11–13). In addition, a link between toxin release and peptidoglycan (PG)
hydrolase (PGH)-induced bacteriolysis has also been suggested (14).
PG is the major component of the bacterial cell wall that helps to maintain cell shape
and confers resistance to internal osmotic pressure (15, 16). PG is composed of linear
glycan strands made of alternating N-acetylglucosamine (NAG) and N-acetylmuramic
acid (NAM) and cross-linked by short peptides. PG is constantly remodeled during
bacterial growth and division to allow the incorporation of new PG subunits and to
accommodate changes in cell shape. This remodeling requires PG-degrading enzymes
capable of cleaving certain covalent bonds of the cell wall PG (17). PGHs represent a key
class of enzymes responsible for hydrolyzing PG bonds. Four different PGH activities are
defined according to the chemical bond cleaved inside the PG molecule as follows:
N-acetylmuramyl-L-alanine amidase, endopeptidase, N-acetylglucosaminidase, and
N-acetylmuramidase (18). Another common family of PG-degrading enzymes is that of
the lytic transglycosylases (LTs). LTs cleave the same bonds as muramidases, but they
are not hydrolases since they use the C-6 hydroxyl of NAM rather than water as a
nucleophile in the cleavage reaction, yielding a product ending with 1,6-anhydroNAM
(19). PG-degrading enzymes contribute to various physiological functions such as cell
wall expansion, cell wall turnover, and daughter cell separation after division (17, 20).
PG-degrading enzymes also include bacterial autolysins, whose activity may lead to
autolysis and consequently to release of the intracellular content under specific con-
ditions, such as exposure to a stress (21). Finely tuned regulation of the PG-degrading
enzyme activity is therefore essential for bacterial survival (22). In addition to their
functions in the bacterial physiology, many autolysins of Gram-positive bacteria are
implicated in pathogenicity by mediating bacterial adherence or by releasing virulence
factors and can be required for full virulence in animal models. These include Atl and
Sle1 in Staphylococcus aureus (23, 24); AtlE in S. epidermidis (25); LytA, LytB, and LytC in
Streptococcus pneumoniae (26–29); and IspC, Auto, and p60 in Listeria monocytogenes
(30–32).
Very little is known about the PG-degrading enzymes in C. difficile. Acd, a PGH with
N-acetylglucosaminidase activity, and two proteins exhibiting N-acetylmuramyl-L-
alanine amidase activity, the CD11 and CDG enzymes, have been identified, but their
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physiological functions have not yet been investigated (33, 34). In addition, SleC, a
spore cortex lytic enzyme with LT activity, has been shown to be essential for germi-
nation of C. difficile spores (35, 36). Furthermore, the putative endopeptidase SpoIIQ
was recently shown to be required for normal spore engulfment, although its catalytic
domain seems to be dispensable for this function (37, 38).
In this work, we identified a novel PG-degrading enzyme, Cwp19, with an unchar-
acterized catalytic domain and demonstrated that Cwp19 functions as an LT. Inactiva-
tion of cwp19 decreased Triton X-100-induced autolysis. Moreover, cell autolysis fol-
lowing entry into the stationary phase was remarkably delayed in the cwp19 mutant
compared to the wild-type strain when bacteria were cultivated in brain heart infusion
(BHI) medium. Cell autolysis was accompanied by a reduction of cell wall thickness and
alterations of cell wall integrity. A drastic reduction in toxin secretion was also observed
in the strain lacking Cwp19, suggesting that toxin release was primarily mediated by
Cwp19-induced autolysis in cells grown in BHI medium. However, the growth medium
appeared to significantly influence Cwp19 activity since Cwp19 did not induce
stationary-phase autolysis or toxin release in cells grown in tryptone-yeast extract (TY)
medium. This suggests the contribution of the TcdE-dependent mechanism of toxin
secretion.
RESULTS
Cell wall protein Cwp19 is a peptidoglycanase. PG-degrading enzymes are
classically detected by zymogram assays, in which the substrate (whole bacteria or
bacterial PG) is incorporated into the resolving gel of SDS-PAGE. This allows the assay
to reveal PG-degrading activity of proteins by clear lytic zones in the gel. The pepti-
doglycanase activity of surface proteins extracted from C. difficile 630Δerm was exam-
ined by zymogram with Micrococcus lysodeikticus cells as the substrate. A major lytic
band with a molecular weight of 70 kDa and two minor lytic bands with molecular
weights of around 55 and 50 kDa were detected (Fig. 1A). Using in silico analysis of
catalytic domains of PG-degrading enzymes (18), 32 putative peptidoglycanase-
encoding genes were found in the genome of C. difficile 630 (see Table S1 in the
supplemental material). Several of them (acd, cwp6, CD0961, CD1035, CD1036, CD1108,
and CD2903) encode proteins with a theoretical molecular weight of close to 70 kDa,
making the prediction of the protein responsible for the major hydrolytic activity
detected by zymogram assay difficult. To identify the 70-kDa PG-degrading enzyme,
surface proteins of C. difficile 630Δerm were separated by SDS-PAGE and proteins with
a size around 70 kDa were excised from the gel and digested with trypsin and tryptic
peptides were analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/
MS). Three different proteins were thus identified: the well-characterized cysteine
protease Cwp84 (39, 40), the surface layer (S-layer) precursor protein SlpA (41), and the
cell wall protein Cwp19. Surprisingly, none of the peptidoglycanases predicted from the
in silico analysis were found among the identified proteins.
Cwp19 is a putative surface-associated protein of 703 amino acids with a predicted
molecular weight of 77.8 kDa and a pI of 8.99. This protein has a putative 24-amino acid
signal sequence, a C-terminal domain containing three tandem copies of the cell wall
binding motif CWB2 (Pfam04122), and a putative N-terminal catalytic domain belong-
ing to the glycosyl hydrolase-like 10 family (GHL10) (Pfam02638) (Fig. 1B). Cwp19 is
conserved in every genome available for C. difficile. Moreover, the GHL10 domain is
widely distributed in bacterial species (Table S2). At the time of our study, we found in
the Pfam database 1,642 GHL10 domain-containing proteins from 871 organisms (42).
These proteins are frequently found in members of the Gram-positive phyla Firmicutes
and Actinobacteria as well as in Gram-negative bacteria, including members of the
phyla Bacteroidetes, Cyanobacteria, and Proteobacteria.
To check that the lytic activity detected as a 70-kDa band was associated with
Cwp19, we generated a C. difficile cwp19 mutant using a ClosTron system (see Fig. S1 in
the supplemental material). Zymogram analysis of surface proteins of the cwp19
mutant strain revealed the loss of the major 70-kDa lytic band present in the wild type.
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The minor band of 50 kDa was also absent in the mutant strain, suggesting that this
band was due to an active Cwp19 degradation product (Fig. 1A). In contrast, the middle
55-kDa band was still present, indicating the presence of another active peptidogly-
canase. Complementation of the cwp19 mutant with a plasmid harboring the wild-type
copy of the cwp19 gene expressed with its promoter restored the major and the minor
hydrolytic bands observed in the 630Δerm strain (Fig. 1A), thus confirming that Cwp19
is responsible for the major lytic band observed on the zymogram. Therefore, our data
demonstrate that Cwp19 is a peptidoglycanase, a result recently reported by Bradshaw
et al. from preliminary activity tests (43).
Cwp19 has lytic transglycosylase specificity. To provide further evidence that
Cwp19 functions as a PG-degrading enzyme and to examine its hydrolytic activity, we
first attempted to produce and purify a recombinant His6-tagged Cwp19 protein in
Escherichia coli. However, despite multiple attempts and diverse constructions, purifi-
cation of recombinant Cwp19 resulted in poor yields and multiple degradation prod-
ucts. Similar Cwp19 purification issues in E. coli were previously reported (44). There-
fore, we decided to overexpress Cwp19 in C. difficile using an inducible system. Cwp19
was expressed with its native signal peptide and a C terminus His6 tag on a plasmid
under the control of the inducible Ptet promoter in C. difficile 630Δerm. Recombinant
His6-tagged Cwp19 was thus successfully purified and visualized as a single protein
band near 70 kDa in SDS-PAGE. The identity of the purified His6-Cwp19 was further
FIG 1 Cwp19 is a PG-degrading enzyme. (A) Detection of bacteriolytic activities in surface protein
extracts of C. difficile 630 Δerm (WT), cwp19 mutant (mut.), and complemented cwp19 mutant (comp)
strains by zymogram. The gel contained 0.2% (wt/vol) M. lysodeikticus cells as a substrate. Surface
proteins were extracted from cells grown to the exponential phase in BHI medium. Arrows indicate the
positions of the bacteriolytic bands. (B) Schematic representation of Cwp19. The relevant characteristics
are a signal peptide (SP), a putative catalytic domain (GHL10), and three copies of a cell wall binding
motif termed CWB2. (C) Analysis of purified His6-tagged Cwp19 by SDS-PAGE (left panel), Western
blotting performed with anti-His antibody (middle panel), and zymogram assay (right panel).
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confirmed by Western blotting with anti-His6 antibodies (Fig. 1C). Moreover, purified
His6-Cwp19 caused a strong zone of clearing in a zymogram assay using M. lysodeikticus
cells as the substrate, confirming the PG-degrading activity of the purified Cwp19
protein (Fig. 1C).
The cleavage specificity of Cwp19 was then determined by assaying the activity of
the purified His6-Cwp19 on vegetative PG of C. difficile 630Δerm. However, no peaks
were observed when reaction supernatants were analyzed by reverse-phase high-
pressure liquid chromatography (RP-HPLC), indicating that no soluble PG fragments
had been generated. We reasoned that since His6-Cwp19 could lyse M. lysodeikticus
cells in a zymogram assay, PG of M. lysodeikticus might constitute a suitable substrate
to characterize the cleavage specificity of Cwp19. Therefore, purified PG of M. lysodeik-
ticus was incubated with purified His6-Cwp19. RP-HPLC separation of the soluble
fraction revealed the presence of several peaks (Fig. 2A). In contrast, no peaks were
detected in a control reaction with M. lysodeikticus PG incubated without adding
His6-Cwp19 (Fig. 2A). The main reaction products (peaks A to G in Fig. 2A) were
analyzed by matrix-assisted laser desorption ionization–time of flight mass spectrom-
etry (MALDI-TOF MS) and by MALDI-TOF/TOF tandem MS (MS/MS), and the resulting
data were used to predict consistent structures (Table 1). Two muropeptides (present
in peaks C and E) with m/z values of 957.55 and 1,028.59, respectively, were identified
as 1,6-anhydromuropeptides bearing a terminal nonreducible 1,6-anhydroNAM resi-
due. This proposed structure was deduced from the observation of appropriate prod-
uct ions in the corresponding MS/MS spectrum (Fig. 2B; see also Fig. S2). The muro-
peptide in peak B had the same m/z value as another species also present in peak C
and was therefore proposed to have the same structure. The occurrence of 1,6-
anhydromuramoyl-containing muropeptides in the PG digestion products indicates
that Cwp19 has LT activity. Interestingly, no other structure among the other charac-
terized PG fragments was shown to contain a terminal 1,6-anhydroNAM residue.
Regarding the products below peaks D and G, their m/z values were consistent with
those of tetrasaccharidic structures with a reducing end and bearing a single peptidic
side chain (Table 1). The MS/MS fragmentation patterns of these two parent ions were
in line with the proposed structures and further indicated that the peptide chains of
both muropeptides might be linked to the internal NAM of the tetrasaccharide chain
(Fig. S3A and B). Both the amino acid composition of the stem peptides and the
presence of unsubstituted NAM are in agreement with the structure of the cell wall PG
of M. lysodeikticus established by Schleifer and Kandler (45). Regarding peaks A and F,
MS/MS analysis indicated that the corresponding PG fragments might contain tetrasa-
ccharides with an unsubstituted NAM reducing end (data not shown).
In summary, we identified the typical anhydromuropeptides resulting from LT
activity in addition to several reaction products containing a reducing end (compounds
corresponding to peaks A, D, F, and G). Similarly, PG fragments with a terminal reducing
end have been previously reported to be reaction products of Bacillus subtilis and E. coli
LTs, especially for enzymes exhibiting low activity in vitro (46–48). These products are
proposed to be formed when the transient oxocarbenium intermediate entraps a water
molecule instead of the C6-hydroxyl group of NAM, giving rise to hydrolytic cleavage
of the NAM-NAG glycosidic bond (muramidase activity) rather than to nonhydrolytic
cleavage resulting in anhydroNAM formation (LT activity). Therefore, we conclude that
Cwp19 is an LT on the basis of our overall results. Interestingly, the reducing end-
containing products that we identified as Cwp19 digestion products have a terminal
unsubstituted NAM. We infer that the absence of peptide stem might interfere with the
normal reaction mechanism of the LT and might lead to hydrolytic cleavage of the
glycosidic bond.
Transcription of cwp19 during growth. The cwp19 mRNA levels were monitored
during the bacterial growth in BHI medium by quantitative reverse transcription-PCR
(qRT-PCR). Variation in cwp19 expression was limited over time, with maximum expres-
sion at 10 h and the lowest level at 48 h (Fig. 3A). The cwp19 promoter was mapped
Autolysis and Toxin Release in Clostridium difficile ®
May/June 2018 Volume 9 Issue 3 e00648-18 mbio.asm.org 5
 on June 25, 2019 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
FIG 2 Cwp19 is a lytic transglycosylase. (A) RP-HPLC separation of soluble PG fragments released from M. lyso-
deikticus PG after incubation with buffer (Untreated) or His6-Cwp19 (Cwp19-treated). Annotated peaks were
collected and their masses determined by MALDI-TOF MS. (B) MALDI-TOF/TOF tandem MS spectrum of the reaction
product in peak C. The [MNa] parent ion (m/z 957.55) was selected for fragmentation, and the inferred structure
is represented at the bottom of the panel. The fragments were also detected as sodiated ions.
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by rapid amplification of cDNA ends (RACE)-PCR. The apparent transcriptional start site
of cwp19 was located 47 bases upstream of its translational start codon (Fig. 3B). It was
previously reported that the genes encoding the major autolysins LytC, LytD, and LytF
in B. subtilis are transcribed by the RNA polymerase containing the alternative sigma
factor D (49, 50). However, we could not identify the described consensus sequence
of C. difficile D-dependent promoters upstream of the transcriptional start site of
cwp19 (51). We found instead putative 10 (TATACT) and 35 sequences (TTGACA),
resembling those of A-dependent promoters. In addition, expression of cwp19 was not
affected in a D mutant (51). Overall, these results suggest that cwp19 is primarily
transcribed by A.
Impact of cwp19 inactivation on cell separation and autolysis. Light microscopy
analysis of cells in the exponential-growth phase revealed no effect on daughter cell
separation in the absence of Cwp19 (data not shown). To determine if Cwp19 functions
as an autolysin, a Triton X-100-induced-autolysis assay was performed on cells har-
vested during exponential growth in BHI medium. As shown in Fig. 3C, cellular lysis was
rapid when the wild-type cells were resuspended in the presence of 0.01% Triton X-100.
The autolysis of the cwp19 mutant strain was slower than that of the wild-type
strain, while complementation of the cwp19 mutant restored the wild-type phenotype
(Fig. 3C). Thus, Cwp19 appears to be a major autolysin of C. difficile.
Cwp19 is involved in stationary-phase autolysis in BHI medium. C. difficile
630Δerm grown in BHI medium lysed dramatically during the stationary phase as
revealed by the fast decrease of the optical density at 600 nm (OD600) of the bacterial
culture (Fig. 4A) (14). To test whether Cwp19 was involved in the observed stationary-
phase autolysis, we monitored growth of the wild-type 630Δerm strain and the cwp19
mutant in BHI medium (Fig. 4A). The two strains exhibited the same growth rate
and had similar behavior until 9 h after inoculation. At this point, the wild-type strain
showed a rapid decrease of OD600 with a minimal OD600 reached after 33 h of
incubation in BHI medium. A strong delay in cell lysis was observed in the cwp19
mutant, which required 72 h of incubation to reach the same minimal OD600 as the
wild-type strain. A similar decline phase was observed in comparisons between the
complemented strain and the wild-type strain. We noted that the complemented strain
had a growth defect compared to the wild type, reaching a lower final OD600. This was
probably due to the higher level of Cwp19, expressed from a multicopy plasmid,
causing premature cell lysis during the exponential growth. Similar growth and lysis
features were obtained when the strains were grown for 100 h in an automatic plate
reader (Fig. S4A).
To confirm that the OD decrease was a direct consequence of bacteriolysis, the
release of cytosolic lactate dehydrogenase (LDH) into the supernatant was followed
over time (Fig. 4B). In agreement with the autolysis profiles, the levels of extracellular
LDH activity were lower in the cwp19 mutant than in the wild type and the comple-
mented strains at 30 and 54 h.
TABLE 1 Proposed structures and molecular masses of PG fragments resulting from the
digestion of M. lysodeikticus PG by purified His6-Cwp19
Peaka Proposed structureb
m/z ([MNa] )c
Observed Calculated
B NAG-AnhNAM-L-Ala-D-iGlu-(Gly)L-Lys-D-Ala 957.55 957.40
C NAG-AnhNAM-L-Ala-D-iGlu-(Gly)L-Lys-D-Ala 957.55 957.40
D NAG-NAM-(L-Ala-D-iGlu-[Gly]L-Lys-D-Ala)NAG-NAM 1,455.79 1,455.61
E NAG-AnhNAM-L-Ala-D-iGlu-(Gly)L-Lys-D-Ala-(D-Ala) 1,028.59 1,028.44
G NAG-NAM-(L-Ala-D-iGlu-[Gly]-L-Lys-[D-Ala-L-Lys])NAG-NAM 1,583.93 1,583.70
aPeak letters correspond to Fig. 2.
bThe structures were deduced according to the previously determined structure of M. lysodeikticus PG (45).
NAG, N-acetylglucosamine; NAM, N-acetylmuramic acid; AnhNAM, 1,6-anhydroNAM; iGlu, isoGlu.
cSodiated molecular ions are the most abundant on MALDI-TOF mass spectra for all PG fragments. m/z
values correspond to monoisotopic masses.
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To explore the possible link between cell lysis and cell wall integrity, we analyzed by
transmission electron microscopy (TEM) the wild-type, cwp19 mutant, and comple-
mented strains grown for 33 h in BHI broth (i.e., when the difference of OD600 was the
biggest; see Fig. 4A). In the wild-type strain, almost all (96%) of the cells observed were
lysed cells with an extremely thin cell wall and emptied of their cytoplasmic content
(Fig. 4C). In contrast, the cell wall of the cwp19 mutant cells was intact and well defined,
and almost no (8%) lysed cells were observed. As expected, the complemented cwp19
mutant showed the same thin cell walls and wall perforations as the wild-type strain
(Fig. 4C). Taken together, these results demonstrate that Cwp19 plays a major role in
stationary-phase autolysis of C. difficile cells when the cells are grown in BHI medium.
Toxin release is mediated by Cwp19 autolysin in BHI medium. It has previously
been suggested that bacteriolysis is responsible for the release of toxins A and B of
C. difficile 630Δerm (14). Interestingly, all experiments in the study by Olling et al. were
conducted in BHI medium. To determine the impact of Cwp19 on toxin release, the
toxin levels in the cell cytosol and culture supernatants were monitored in the wild type
FIG 3 Expression and autolytic activity of Cwp19 in BHI medium. (A) qRT-PCR analysis of cwp19
expression during cellular growth in BHI medium. Total RNAs were extracted from C. difficile 630Δerm
grown in BHI medium at different times of growth. cDNAs were prepared and qRT-PCR was performed
using gene-specific primers as outlined in Materials and Methods. Cells incubated for 5 h served as the
reference condition. *, P  0.05 (Student’s t test). (B) Schematic representation of the genetic organiza-
tion of the cwp19 chromosomal region of C. difficile strain 630Δerm. Large arrows represent the genes,
and their orientation shows the transcriptional direction. The nucleotide sequence of the cwp19
promoter region is shown. The transcriptional initiation nucleotide (1) identified by 5= RACE, the
putative ribosome binding site sequence, the 10 and 35 motifs, and the translational initiation codon
are underlined. (C) Triton X-100-induced autolysis of the C. difficile wild type (), cwp19 mutant (), and
complemented cwp19 mutant (Œ) grown in BHI medium. The strains were harvested in the exponential-
growth phase and transferred in 50 mM potassium phosphate buffer (pH 7.0) containing 0.01% Triton
X-100. Autolysis was monitored by measuring the decrease of the bacterial suspension at OD600 and is
expressed as a percentage of the initial OD600 value. Error bars indicate standard deviations. Values are
given as means  standard deviations (n  3).
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and in the cwp19 mutant and its complemented strain at different times of growth in
BHI medium. For all strains, toxins were produced after 9 h of growth and their
localization was intracellular (Fig. 4D and E). However, the location of the toxin for the
wild-type strain shifted from the cytosol to the culture supernatant after 30 h of growth,
which correlated with the cell lysis observed in Fig. 4A. In contrast, toxin release into the
supernatant was strongly delayed in the cwp19 mutant (Fig. 4D and E). The release
FIG 4 Role of Cwp19 in cell autolysis and toxin release of C. difficile cultivated in BHI medium. (A) Growth
and autolysis of the wild-type 630Δerm (), cwp19 mutant (), and complemented cwp19 mutant (Œ)
strains in BHI medium. Values are given as means  standard deviations (n  3). (B) LDH activity released
in the supernatant fractions of wild-type 630Δerm (black bars), cwp19 mutant (gray bars), and comple-
mented cwp19 mutant (white bars) strains in BHI medium at different time points. LDH activity was
determined using Promega CytoTox 96. The signal from the test was recorded as absorbance at 490 nm.
Values are given as means  standard deviations (n  3). *, P  0.05 (Student’s t test). (C) TEM
micrographs of C. difficile wild-type 630Δerm, cwp19 mutant (cwp19 mut.), and complemented cwp19
mutant (comp.) strains incubated for 33 h in BHI medium. The percentage of damaged cells for each
strain is indicated. (D and E) Toxin titers in the cytosol (D) and in the culture supernatant (E) of wild-type
630Δerm (black bars), cwp19 mutant (gray bars), and complemented cwp19 mutant (white bars) strains
grown in BHI medium. Toxins were quantified by ELISA. The signal from the test was recorded as
absorbance at 450 nm. Values are given as means  standard deviations (n  3). *, P  0.05 (Student’s
t test). ND, not detectable.
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pattern recorded for the wild type was also observed for the complemented cwp19
mutant strain, which is in agreement with its autolysis profile (Fig. 4A, D, and E).
Surprisingly, an increase in the intracellular levels of toxins was observed between 54
and 80 h for the wild-type strain (Fig. 4D). This secondary toxin production was
associated with a slight increase in the OD600 (Fig. 4A) that might have been due to the
growth of surviving cells using lysed cells, as cytoplasmic content can act as a source
of nutrients in a nutrient-depleted environment.
Taken together, these results show that Cwp19 plays a critical role in toxin release
of C. difficile 630Δerm cultivated in BHI medium.
Toxin release is independent of Cwp19-induced autolysis in TY medium. In
apparent discrepancy with the results presented in this study and those of Olling et al.
(14), Govind and Dupuy have shown that secretion of C. difficile toxins A and B is
mediated by the holin-like TcdE protein, independently of the bacterial cell lysis (12).
However, it is worth noting that TY medium instead of BHI medium was used in the
latter study. Thus, we sought to determine the impact of Cwp19 activity in toxin release
from cells cultivated in TY medium. We observed that cell autolysis of the wild-type
strain was much slower in TY medium than in BHI medium (Fig. 4A and 5A). The cwp19
mutant did not show delayed autolysis compared to the wild type, indicating that the
cell lysis occurring in TY medium was largely Cwp19 independent. Surprisingly, muta-
tion of cwp19 rather slightly accelerated cell lysis after 48 h of incubation (Fig. 5A). The
same lysis kinetic as was seen with the wild type was observed in the complemented
cwp19 mutant strain, even though the maximal OD600 reached in this strain was lower.
The same conclusions could be drawn when strains were grown in TY medium for 100 h
in an automatic plate reader (Fig. S4B).
LDH levels in the supernatants of the three strains were in complete agreement with
their lysis profiles and were slightly higher in the cwp19 mutant than in the wild-type
strain at 54 h (Fig. 5B). In addition, TEM was performed on cells cultivated in TY medium
for 48 h, the time point when cell lysis occurs, which is different between the wild type
and the mutant strain. While most of the cells of the wild-type and complemented
strains were intact, a subpopulation of lysed cells was observed in the cwp19 mutant
(Fig. 5C). Thus, the absence of Cwp19 seems to stimulate the activity of another
nonidentified PGH in TY medium.
Both intracellular toxin levels and accumulations of toxins in the supernatant were
correlated with cell lysis (Fig. 5D and E). Most of the toxin release occurred after
prolonged incubation times and could be attributed to Cwp19-independent cell lysis
(Fig. 5A and E). However, low but significant toxin levels were detected in the extra-
cellular medium after 9 h in TY medium. Cell lysis does not occur at that time,
suggesting that early toxin release might be mediated by a TcdE-dependent secretion
mechanism (12). The cwp19 mutant released more toxins into the supernatant than the
wild type after 54 h, in agreement with cell lysis results. Notably, the cwp19 mutant
strain also produced slightly lower total levels of toxins than the wild type after 9 h of
incubation (Fig. 5D).
Cwp19 is produced and active in cells grown in TY medium. Since Cwp19 does
not contribute to cell autolysis in TY medium, we sought to determine whether Cwp19
was produced and active under these conditions. Analysis by qRT-PCR revealed that
cwp19 is transcribed during the bacterial growth in TY medium (data not shown).
Zymogram analysis of surface proteins of the wild-type and cwp19 mutant strains
grown in TY medium gave profiles of lytic bands (Fig. S5A) similar to the one observed
in BHI medium (Fig. 1A). The 70-kDa and 50-kDa lytic bands corresponding to Cwp19
detected in the wild type disappeared in the cwp19 mutant, confirming that Cwp19 is
produced in an active form in TY medium. Furthermore, Triton X-100-induced autolysis
of the wild-type, cwp19 mutant, and complemented cwp19 mutant strains was tested.
Autolysis of the cwp19 mutant strain was dramatically slower than that of the wild-type
strain or the complemented cwp19 strain (Fig. S5B). Thus, Cwp19 is synthesized and
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active when C. difficile 630Δerm is cultivated in TY medium but does not play a major
role in cell autolysis or, consequently, in toxin release during the stationary phase.
Glucose influences Cwp19-dependent lysis. Both BHI and TY are rich media, but
BHI medium contains 0.2% glucose. To examine whether the presence of glucose might
impact Cwp19-mediated lysis, wild-type and cwp19 mutant strains were grown for
FIG 5 Role of Cwp19 in cell autolysis and toxin release of C. difficile cultivated in TY medium. (A) Growth
and autolysis of wild-type 630Δerm (), cwp19 mutant (), and complemented cwp19 mutant (Œ) strains
in TY medium. Values are given as means  standard deviations (n  3). (B) LDH activity released in the
supernatant fractions of wild-type 630Δerm (black bars), cwp19 mutant (gray bars), and complemented
cwp19 mutant (white bars) strains in TY medium at different time points. LDH activity was determined
using Promega CytoTox 96. The signal from the test was recorded as absorbance at 490 nm. Values are
given as means  standard deviations (n  3). *, P  0.05 (Student’s t test). (C) TEM micrographs of
C. difficile wild-type 630Δerm, cwp19 mutant (cwp19 mut.), and complemented cwp19 mutant (comp.)
strains incubated for 48 h in TY medium. The percentage of damaged cells for each strain is indicated.
(D and E) Toxin titers in the cytosol (D) and in the culture supernatant (E) of wild-type 630Δerm (black
bars), cwp19 mutant (gray bars), and complemented cwp19 mutant (white bars) strains grown in TY
medium. Toxins were quantified by ELISA. The signal from the test was recorded as absorbance at
450 nm. Values are given as means  standard deviations (n  3). *, P  0.05 (Student’s t test).
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100 h in TY medium supplemented with 0.2% glucose (TYG) and growth was monitored
in an automatic plate reader (Fig. S4C). While Cwp19 did not induce cell autolysis in TY
medium (Fig. S4B), the cwp19 mutant lysed less than the wild-type strain in TYG.
Therefore, this result indicates that glucose plays an important role in the control of
Cwp19-dependent lysis, possibly by modifying cell surface features and thus facilitating
access of Cwp19 to its PG substrate.
DISCUSSION
In this study, we characterized a surface protein of C. difficile (Cwp19) with PG-
degrading activity and we showed that it is involved in autolysis and toxin release after
stationary-phase entry. Cwp19 has a novel catalytic domain named GHL10, previously
known as DUF187 (41), which does not belong to any known domains specialized in
cleavage of PG bonds in Firmicutes (see Table S1 in the supplemental material) (18).
Thus, we report for the first time that the GHL10 domain, which is widely distributed in
bacterial species, is a novel domain conferring PG-degrading activity and, more spe-
cifically, LT activity.
The first LT was discovered more than 40 years ago in E. coli (52), and six different
catalytic domains with LT activity have since been identified in Gram-negative bacteria
(53). In contrast, only a few LTs have been characterized in Gram-positive bacteria. Most
of them are specific to spore-forming bacteria and are involved in the processes of
spore formation or germination (53). In this study, we demonstrated that Cwp19 is
synthesized in C. difficile vegetative cells and that Cwp19 activity leads to autolysis in
stationary phase. Cwp19 does not have any sequence homology to known LTs and
therefore represents the founding member of a widely distributed family of LTs.
Cwp19 belongs to the large family of C. difficile cell wall proteins (CWPs) comprising
29 members (41, 54). These proteins contain three tandem CWB2 motifs (Pfam04122),
which mediate the attachment of CWPs to the cell wall through interactions with the
anionic polymer PSII (55, 56). Several CWPs have been previously characterized in
C. difficile. These include the S-layer proteins, the Cwp2 and Cwp66 adhesins, the
phase-variable CwpV protein, and the Cwp13 and Cwp84 proteases (54, 57–59). Al-
though the exact role of each CWP in pathogenesis remains to be elucidated, antibod-
ies to many CWPs have been found in serum samples from C. difficile-infected patients,
implying that certain CWPs are expressed and surface exposed in vivo (60, 61). Cwp19
is one of the CWPs present at the cell surface in vivo and expressed during the early
step of colonization (61, 62). This suggests that Cwp19 could have an important role
during the infection process of C. difficile.
While purified His6-Cwp19 readily digested M. lysodeikticus PG, it failed to generate
a soluble fragment from PG purified from C. difficile. We believe this could have been
due to structural modifications in the PG substrate, which are known to affect pepti-
doglycanase activity (63). Glycan chains of PG of C. difficile exhibit very high (approx-
imately 93%) levels of NAG deacetylation (64). The degree of NAG deacetylation
modulates lysozyme resistance in C. difficile (65), as well as in many Gram-positive
bacteria (66). Moreover, NAG deacetylation has been shown to modulate activity of
endogenous PGHs in bacteria, such as AcmA in Lactococcus lactis or LytA in S. pneu-
moniae (67, 68). All PG fragments generated from digestion of M. lysodeikticus PG
contained acetylated NAG residues, and it is therefore possible that Cwp19 would not
cleave the (1-4) bond between a NAM and an N-unsubstituted glucosamine. Accord-
ing to this model, C. difficile PG, which contains only low levels of NAM-NAG glycosidic
bonds, would be cleaved to a much lesser extent by Cwp19. Thus, soluble PG fragments
are probably generated but such fragments are likely too large for HPLC analysis. How
could Cwp19 activity lead to cell autolysis while having such limited cleavage sites in
C. difficile PG? One hypothesis is that the rare NAG residues might not be randomly
distributed around the cells but rather might be randomly distributed at key locations
and that the cleavage of the NAG-NAM glycosidic bonds would destabilize the entire
PG network. An alternative possibility is that Cwp19 makes small breaches inside the PG
network, facilitating access for other PG-degrading enzymes.
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In S. pneumoniae, the major autolysin LytA, with N-acetylmuramoyl-L-alanine ami-
dase activity, causes dramatic autolysis of bacteria at the stationary phase (26, 69) and
is thought to contribute to pneumococcal virulence by releasing the cytoplasmic
content, including the pneumolysin toxin (26, 27). Interestingly, LytA does not induce
cell lysis during the logarithmic-growth phase, although it is present at the cell surface,
suggesting that the PG is somehow protected from the lytic activities of LytA (70). In
our study, we have shown that Cwp19 is transcribed during the exponential-growth
phase. Moreover, Triton X-100-induced autolysis from cells in the exponential phase of
growth revealed an important and immediate role of Cwp19. Since Cwp19 is cell wall
associated, these results suggest that Cwp19 cannot exert its influence on the PG
during exponential growth, as observed for LytA in S. pneumoniae. The mechanism that
initiates Cwp19-mediated cell wall degradation remains unclear but it is likely linked to
cell wall modifications that occur when cells enter the stationary phase. Secondary cell
wall polymers, including teichoic acids (wall teichoic acids and lipoteichoic acids) and
polysaccharides, can modulate autolytic activity by shielding PG (71). In C. difficile 630,
two types of surface polysaccharides have been described: the wall teichoic-like PSII
acids and the PSIII lipoteichoic acid (72, 73). Thus, it is possible that protection of PG
against Cwp19 might be conferred by one of these two polymers.
In BHI medium, Cwp19 is the main peptidoglycanase responsible for the C. difficile
cell autolysis triggered at the beginning of the stationary phase. However, autolysis of
the strain lacking Cwp19 was not completely abolished and lysis levels similar to those
seen with the wild type were observed at later time points (Fig. 4A). Cwp19-
independent lysis was also observed when bacteria were grown in TY medium (Fig. 5A).
These observations indicate that Cwp19 is not the only autolysin involved in the lysis
of C. difficile during the stationary phase and highlight the involvement of other
PG-degrading enzymes. Functional redundancy of multiple autolysins has been dem-
onstrated in B. subtilis (20, 74) and is consistent with the large number of putative
autolysins present in C. difficile (Table S1). Interestingly, a lytic band was still present on
the zymogram for the cwp19 mutant and the corresponding unidentified enzyme is the
preferential candidate for this persistent lysis. This enzyme is unlikely to be Acd, the first
autolysin described in C. difficile (33), since inactivation of Acd had no impact on the
bacteriolytic activity profile in a zymogram assay, on Triton X-100-induced autolysis, or
on the stationary-phase autolysis in BHI medium (unpublished data).
The role of the holin-like TcdE protein in the release of C. difficile TcdA and TcdB has
been controversial. On the one hand, it was previously shown that TcdE mediates toxin
release in strain JIR8094 (also referred to as 630E) (12), an erythromycin-sensitive
derivative of strain 630 (ribotype 012) (75) as well as in strain R20291 (ribotype 027)
grown in TY medium (13). On the other hand, a tcdE inactivation did not affect toxin
release in strain 630Δerm, another erythromycin-sensitive derivative of strain 630 that
has been shown to behave differently from strain JIR8094 (76) cultivated in BHI medium
or from strain CD646 (ribotype 078) cultivated in TY medium. This result is mainly
supported by the extensive autolysis that occurs during entry into the stationary phase
in both strains (13, 14). The new model emerging from our findings is that Cwp19-
dependent autolysis is the major mechanism responsible for toxin release in vitro when
630Δerm cells are cultivated in BHI medium (Fig. 4) but not in TY medium (Fig. 5).
Interestingly, when strain 630Δerm was grown in TY medium, significant extracellular
toxin levels were detected as early as 9 h, a time point where cell lysis was not occurring
(Fig. 5E). This result reinforces the idea of a role of TcdE in toxin secretion under this
growth condition (12). Notably, toxin production was approximately 9-fold higher
when strain 630Δerm was grown in TY medium than when it was grown in BHI medium
(Fig. 4C and 5C). This result is in agreement with the repression of toxin expression by
glucose through the carbon catabolic repression system (77, 78) and shows an inverse
correlation between the abundance of toxins produced and the importance of Cwp19-
mediated lysis for toxin release. TcdE-dependent secretion of toxin, which presents the
benefit of preserving the cells from death, might be the preferred mechanism used by
C. difficile when cells are in an environment supporting abundant toxin production. In
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contrast, the toxins released by TcdE in an environment inducing low toxin production
would be insufficient and Cwp19-dependent release of toxins, an efficient but lethal
mechanism, would then be required. In line with this hypothesis, we found that
Cwp19-dependent lysis is also controlled by the presence of glucose (see Fig. S4C in the
supplemental material).
In B. subtilis, autolytic amidases LytC, CwlC, and CwlH are required for hydrolysis of
the mother cell wall peptidoglycan to release the mature endospore (79, 80). In
C. difficile, Cwp19 cleaves the cell wall peptidoglycan after entry into the stationary
phase and might thus play a role in sporulation or in mother cell lysis to release spores.
However, even though inactivation of cwp19 had a slight effect on sporulation effi-
ciency (4% for the wild type and 1% for the mutant strain in BHI medium after 48 h of
growth), the overall sporulation frequency of the 630Δerm strain was low and free
spores were observed in both the wild type and the cwp19 mutant strain (data not
shown). Additionally, most of the wild-type cells grown in BHI medium for 33 h were
severely damaged as observed by TEM (Fig. 4C) but no spores could be observed,
highlighting the lack of correlation between cell lysis and sporulation. Furthermore,
cwp19 is predicted to be transcribed by A and does not depend on the F, E, G, and
K sporulation sigma factors (81). Hence, these data suggest that release of the
endospores from the mother cells is not the primary purpose of Cwp19-mediated cell
lysis.
What is the relevance of Cwp19 in toxin release when C. difficile colonizes the gut?
Answering this question will require the deciphering of the mechanism controlling
Cwp19 activity in response to the gut nutritional status as suggested by the differences
observed in vitro. At this stage, we can assume only that Cwp19 and TcdE are coexisting
mechanisms for toxin release acting independently in response to the nutritional
changes occurring during the infection process. During the colonization phase, C. dif-
ficile does not need to compete for access to nutrients and the cells are probably in a
state of continuous active growth. Therefore, cell lysis would not occur under these
conditions and the release of toxins might be handled by the TcdE-dependent mech-
anism. As infection develops, nutrient availability becomes limited and such limitations
would change the environmental conditions. These changes might induce Cwp19-
mediated autolysis, leading to an important release of toxins. For this mechanism to
have any benefit for C. difficile, it would be required to be asynchronous, with only a
subpopulation of cells initiating it. Thus, the surviving population would profit from the
release of nutrients due to the rupture of the intestinal epithelial cells. Severe diarrhea
would be also induced, and this would contribute to the dissemination of the bacteria
to new and potentially more supportive environments.
This study was focused solely on the 630Δerm strain, but Cwp19 is present in all
C. difficile strains that have been sequenced so far. We assume that this protein plays
a conserved and important role in autolysis and toxin release in a wide range of strains.
Cwp19 may represent an attractive drug target to prevent toxin release during CDI,
and, as such, it would be highly relevant to expand the analysis of Cwp19 function to
other clinically significant strains of C. difficile such as the R20291 strain. Finally, we
demonstrated that Cwp19 PG-degrading activity is controlled by environmental con-
ditions such as nutritional signals. Deciphering both the mechanism controlling the
activity of Cwp19 and the nature of the signals also represents a promising avenue for
another therapeutic approach targeting the induction of C. difficile cell autolysis before
toxin production.
MATERIALS AND METHODS
Bacterial strains and culture conditions. Bacterial strains and plasmids used in this study are listed
in Table S3 in the supplemental material. C. difficile 630Δerm (82) was used in all experiments. C. difficile
strains were routinely cultured on BHI agar (Difco), BHI broth (Difco), or TY broth (77) at 37°C in an
anaerobic environment (80% [vol/vol] N2, 10% [vol/vol] CO2, and 10% [vol/vol] H2). When necessary,
C. difficile culture media were supplemented with cefoxitin (Cfx; 25 mg/liter), cycloserine (Ccs; 250 mg/
liter), thiamphenicol (Tm; 7.5 mg/liter), and erythromycin (Erm; 5 mg/liter). E. coli strains were cultured at
37°C in LB broth or LB agar (MP Biomedicals), containing chloramphenicol (25 mg/liter) or ampicillin
(100 mg/liter) when necessary.
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RNA isolation and quantitative real-time PCR. C. difficile cultures were inoculated from overnight
grown cells in TY or BHI medium at an OD600 of 0.05. Samples of total RNA were isolated from C. difficile
cells with a FastRNA Pro Blue kit (MP Biomedicals). cDNA synthesis and real-time quantitative PCR were
performed as previously described (83, 84). In each sample, the quantity of cDNAs of a gene was
normalized to the quantity of cDNAs of the dnaF gene (CD1305) encoding DNA polymerase III. The
relative change in gene expression was recorded as the ratio of normalized target concentrations
(threshold cycle [ΔΔCT] method) (85).
Mapping of the transcriptional start site. The 5= end of cwp19 mRNA was mapped from a 5= rapid
amplification of cDNA ends (RACE)-PCR product obtained with a 3=/5= RACE kit (Roche Diagnostics).
Briefly, the first-strand cDNA was synthesized from total RNA using primer sp1 (Table S3), avian
myeloblastosis virus (AMV) reverse transcriptase, and the deoxynucleoside triphosphate (dNTP) mixture
of the 3=/5= RACE kit as recommended by the manufacturer. After purification and dG tailing of the cDNA,
a nested PCR using the oligo(dC) anchor primer and the sp2 specific primer was carried out. The PCR
product was purified and sequenced using primer sp3 (Table S3).
Expression and purification of the Cwp19-His6-tagged fusion protein in C. difficile 630 erm.
Primers cwp19surF/cwp19surR flanking cwp19 (Table S3) were used for PCR amplification of the cwp19
coding sequence and its preceding ribosome binding site (RBS) and to add a C-terminal His6 tag. Purified
PCR product was digested with BamHI and XhoI and ligated into pRPF185, under the control of the
anhydrotetracycline (ATc)-inducible Ptet promoter (86), and digested with the same enzymes, yielding
pSUR19. Plasmid pSUR19 was initially transformed into E. coli Top10, and the sequence of the insertion
was verified by sequencing. Plasmid was then transformed into the conjugative donor E. coli HB101 (RP4)
and transferred via conjugation into C. difficile 630Δerm. Cwp19 expression was induced in the presence
of 500 ng/ml ATc for 4 h, and cells were then harvested by centrifugation. After cell disruption using a
single freeze-thaw cycle as previously described (86), the soluble fraction containing the recombinant
protein was purified by affinity chromatography with Talon metal affinity resin (Clontech). The pure
protein was dialyzed and concentrated by ultrafiltration with Amicon Ultra-4 centrifugal filter units
(Millipore) with a 30-kDa cutoff.
Construction of C. difficile cwp19 mutant and cwp19 complemented strains. To generate a cwp19
mutant, a ClosTron system was used as described previously (87). Briefly, the algorithm available on the
TargeTron design site was used to identify intron insertion sites within cwp19. The primers chosen to
retarget the group II intron on pMTL007 to cwp19 were used with EBS universal primer and intron
template DNA to generate a 353-bp DNA fragment by overlap PCR (Table S3). The PCR product was
cloned into the HindIII and BsrGI restriction sites of pMTL007. The sequence of the insertion was verified
by sequencing using pMTL007-specific primers pMTLseq-F and pMTLseq-R (Table S3). Plasmid pMTL007::
cwp19-588s retargeted the group II intron for insertion into the cwp19 gene in the sense orientation
immediately after nucleotide 588 in the coding sequence, i.e., the DNA sequence encoding the catalytic
domain. This derivative pMTL007 plasmid was transformed into the conjugative donor E. coli HB101 (RP4)
and then transferred via conjugation into the C. difficile 630Δerm strain. Transconjugants were selected
by subculturing on BHI agar containing Cfx, Ccs, and Tm and then plated on BHI agar containing Erm.
Erm-resistant (and Tm-sensitive) C. difficile colonies were produced, following plasmid loss and insertion
of the group II intron into the chromosome, which was accompanied by splicing out of the group I intron
from the ermB retrotransposition-activated marker (RAM). Moreover, genomic DNA of Erm-resistant
transconjugants was extracted and was subjected to PCR using primers flanking cwp19 (cwp19 F and
cwp19 R) (Table S3) to verify that the group II intron had inserted into the correct target gene. To
complement the cwp19 mutant, the cwp19 gene with its own promoter was amplified by PCR using
primers cwp19 compF and cwp19 compR (Table S3). The PCR fragment digested by XhoI and PvuI was
cloned into pMTL007 previously digested with the same enzymes, and the resulting plasmid, pCOMP19,
was introduced by conjugation into the C. difficile cwp19 mutant strain, using E. coli HB101 (RP4) as a
donor.
Cell lysis and protein analysis. Whole-cell lysates were prepared as previously described (86). For
cell wall protein extraction, cultures of C. difficile were harvested by centrifugation at 5,000  g for
10 min at 4°C, washed in phosphate buffer saline (PBS), and resuspended in SDS-PAGE sample buffer
(88) to reach an OD600 of 20 and boiled for 10 min. For analysis by SDS-PAGE, an equal volume of
2 SDS sample buffer was added to protein samples (88). SDS-PAGE and Western immunoblotting
were carried out using standard methods. Lytic activities were detected by zymography using
SDS-polyacrylamide gels containing 0.2% (wt/vol) M. lysodeikticus ATCC 4698 cells (Sigma). After
electrophoresis, the gel was shaken at 37°C for 16 h in 50 ml of 25 mM Tris-HCl (pH 8.0) solution
containing 1% (vol/vol) Triton X-100 to allow protein renaturation. Clear bands resulting from lytic
activity were visualized after staining with 1% (wt/vol) methylene blue (Sigma)– 0.01% (wt/vol) KOH
and subsequent destaining with distilled water.
Protein identification by electrospray ionization (ESI)–LC-MS/MS. The protein band of interest
was excised from SDS-PAGE gels. The sample was reduced for 1 h at 50°C using 10 mM dithiothreitol
(DTT) (GE Healthcare) and alkylated with 55 mM iodoacetamide (Sigma) for 1 h in the dark.
Fragments were washed several times with water and ammonium carbonate, dehydrated with
acetonitrile (ACN), and dried. Trypsin digestion was performed overnight with a dedicated auto-
mated system (MultiPROBE II; PerkinElmer). To allow extraction of peptides, the gel fragments were
subsequently incubated twice for 15 min in a H2O/CH3CN solution, once for 15 min in 1% (vol/vol)
formic acid, and once with 100% ACN. Supernatants were pooled into a clean 96-well plate. Peptide
extracts were then dried and solubilized in starting buffer (3% CH3CN– 0.1% formic acid–water) for
chromatographic elution.
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Peptides were analyzed using a nano-LC1200 system coupled to a 6340 Ion Trap mass spectrometer
equipped with an HPLC-chip cube interface (Agilent Technologies, Massy, France). The tandem mass
spectrometry peak lists were extracted using the DataAnalysis program (version 3.4, Bruker Daltonics)
and compared with the protein database using the Mascot Daemon (version 2.1.3) search engine. The
searches were performed with a maximum of one missed cleavage, with no fixed modifications, and with
variable modifications for carbamidomethyl and oxidation of methionines. The identifications from the
tandem mass spectrometry spectra were performed with mass tolerances of 1.6 Da for precursor ions and
0.8 for MS/MS fragments. The determination of at least two peptide sequences with a Mascot score of
over 60 allowed a satisfactory identification of the protein.
Toxin and lactate dehydrogenase (LDH) assays. Total TcdA amounts were quantified in superna-
tants and cytosols from BHI and TY cultures by enzyme-linked immunosorbent assay (ELISA). Briefly,
1.5 ml of culture was taken and pelleted at the indicated time points by centrifugation for 4 min at
13,000 rpm. Bacterial pellets were frozen at 20°C. The supernatants were collected and subjected to
ELISA. The frozen bacteria were thawed, resuspended in PBS, and incubated for 1 h at 37°C under
conditions of agitation. Following sonication, the lysates were centrifuged for 3 min at 13,000 rpm to
eliminate cell debris. Then, the intracellular toxins were subjected to ELISA. A 96-well immuno-plate
(Nunc Maxisorp) was coated overnight at 4°C with 2 g/ml of anti-toxin A rabbit polyclonal antibody
(Abcam, Inc.). The coated wells were washed and incubated with Superblock blocking buffer (Thermo
Fisher Scientific) for 1 h. The wells were then washed and air dried. Appropriate dilutions of samples were
added into the wells, and the plate was incubated at 37°C for 90 min. After washings, 0.2 g/ml of an
anti-toxin A chicken horseradish peroxidase (HRP) antibody (LSBio) was added in each well and the plate
was incubated for 1 h at 37°C. The wells were washed and incubated with a TMB (3,3’,5,5’-
tetramethylbenzidine) substrate solution (Thermo Fisher Scientific) for 15 min in the dark. A volume of
stop solution (H2SO4; 0.2 M) was added into each well, and the signal from the test was recorded as
absorbance at 450 nm.
LDH activity was determined using a CytoTox 96 kit from Promega according to the recommenda-
tions of the supplier.
Autolysis assays. For Triton X-100-induced autolysis, overnight cultures were diluted to an OD600 of
0.05 in BHI broth and grown at 37°C until the OD600 reached 0.5. Cells were harvested, washed twice, and
suspended to an OD600 of 0.5 in 50 mM potassium phosphate buffer (pH 7.0) containing 0.01% Triton
X-100. The OD600 of the bacterial suspension incubated at 37°C was then measured every 20 min to
follow cell lysis.
Determination of hydrolytic bond specificity. PG from C. difficile 630Δerm and M. lysodeikticus
ATCC 4698 vegetative cells was prepared as described previously (64). Purified PG (1 mg dry weight) was
digested with purified recombinant His6-Cwp19 protein (25 g) in sodium phosphate buffer (50 mM;
pH 6.0) for 24 h at 37°C with shaking. Samples were boiled for 3 min to stop the reaction, and the
insoluble material was removed by centrifugation at 14,000  g for 15 min. The soluble muropeptides
obtained after digestion were reduced with sodium borohydride and were then separated by reverse-
phase ultra-high-pressure liquid chromatography (RP-UHPLC) with a 1290 chromatography system
(Agilent Technologies) and a Zorbax Eclipse Plus C18 RRHD column (Agilent Technologies) (100 by
2.1 mm; particle size, 1.8 m) at 50°C using ammonium phosphate buffer and a methanol linear gradient
(89). One microliter of collected muropeptides was then spotted directly on the MALDI target and
thoroughly mixed with 1 l of -cyano-4-hydroxycinnaminic acid solution (5 mg/ml–50% ACN– 0.1%
trifluoroacetic acid [TFA]). Muropeptides were analyzed by MALDI-TOF MS with an UltrafleXtreme
instrument (Bruker Daltonics, Bremen, Germany). MS spectra were acquired at a 2-kHz laser repetition
rate in the positive reflector ion mode, with a 20-kV acceleration voltage and an extraction delay of
130 ns. The spectra are obtained by accumulating 1,000 to 5,000 shots (depending on the samples) over
the 500 to 5,000 m/z range. Putative muropeptide structures were proposed based on MS/MS spectra
acquired in LIFT mode at a 1-kHz laser repetition rate, applying 7.5 kV for initial acceleration of ions and
19 kV for reacceleration of fragments in the LIFT cell.
Transmission electron microscopy. Cells of C. difficile were collected after 33 h of growth in BHI
medium or 24 h of growth in TY medium, centrifuged, and washed in PB {0.05 M PIPES [piperazine-
N,N=-bis(2-ethanesulfonic acid)] buffer, 5 mM CaCl2, pH 7.3}. Each sample was fixed overnight at 4°C in
PB containing 2.5% glutaraldehyde and 2% paraformaldehyde. The samples were postfixed first in PB–1%
osmium tetroxide (45 min at 4°C) and then in 1% aqueous uranyl acetate solution for 2 h at room
temperature. The samples were then dehydrated in increasing concentrations of ethanol (30%, 50%,
70%, 95%, and 100%) followed by ethanol/propylene oxide (1/1 [vol/vol]) and propylene oxide and were
finally embedded in Epon epoxy resin. Ultrathin (80-nm) sections were stained with lead citrate and
imaged at 80 kV in a Jeol-100S transmission electron microscope.
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